Seuraa
Caroline Ford
Caroline Ford
UNSW
Vahvistettu sähköpostiosoite verkkotunnuksessa unsw.edu.au - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Sensing extracellular matrix: an update on discoidin domain receptor function
WF Vogel, R Abdulhussein, CE Ford
Cellular signalling 18 (8), 1108-1116, 2006
4532006
The untapped potential of ascites in ovarian cancer research and treatment
CE Ford, B Werner, NF Hacker, K Warton
British journal of cancer 123 (1), 9-16, 2020
2212020
Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma
CE Ford, SK Lau, CQ Zhu, T Andersson, MS Tsao, WF Vogel
British journal of cancer 96 (5), 808-814, 2007
1782007
Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women
CE Ford, D Tran, YM Deng, VT Ta, WD Rawlinson, JS Lawson
Clinical cancer research 9 (3), 1118-1120, 2003
1392003
The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
YN Loh, EL Hedditch, LA Baker, E Jary, RL Ward, CE Ford
BMC cancer 13, 1-9, 2013
1382013
The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells
CE Ford, E Jary, SSQ Ma, S Nixdorf, VA Heinzelmann-Schwarz, RL Ward
PloS one 8 (1), e54362, 2013
1162013
The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis
CE Ford, SS Qian Ma, A Quadir, RL Ward
International journal of cancer 133 (4), 779-787, 2013
922013
Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
FCE Henry C, Quadir A, Hawkins NJ, Jary E, Llamosas E, Kumar D, Daniels B ...
J Cancer Res Clin Oncol 141, 2015
852015
Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
C Henry, E Llamosas, A Knipprath-Meszaros, A Schoetzau, E Obermann, ...
Oncotarget 6 (37), 40310, 2015
822015
Evaluation of Streck BCT and PAXgene stabilised blood collection tubes for cell-free circulating DNA studies in plasma
K Warton, NL Yuwono, MJ Cowley, MJ McCabe, A So, CE Ford
Molecular diagnosis & therapy 21, 563-570, 2017
792017
Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women
CE Ford, M Faedo, R Crouch, JS Lawson, WD Rawlinson
Cancer research 64 (14), 4755-4759, 2004
782004
The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer
CE Ford, G Punnia-Moorthy, CE Henry, E Llamosas, S Nixdorf, J Olivier, ...
Gynecologic oncology 134 (2), 338-345, 2014
772014
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients
F Jacob, K Ukegjini, S Nixdorf, CE Ford, J Olivier, R Caduff, JP Scurry, ...
PloS one 7 (2), e31885, 2012
732012
Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
CE Henry, E Llamosas, A Djordjevic, NF Hacker, CE Ford
Oncogenesis 5 (5), e226-e226, 2016
682016
Mouse mammary tumor virus-like RNA transcripts and DNA are found in affected cells of human breast cancer
CE Ford, M Faedo, WD Rawlinson
Clinical cancer research 10 (21), 7284-7289, 2004
602004
The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma
NL Yuwono, K Warton, CE Ford
Elife 10, e69679, 2021
532021
The Wnt pathway: a key network in cell signalling dysregulated by viruses
WJ van Zuylen, WD Rawlinson, CE Ford
Reviews in medical virology 26 (5), 340-355, 2016
502016
An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target
A Coopes, CE Henry, E Llamosas, CE Ford
Endocrine-related cancer 25 (12), R647-R662, 2018
472018
Mouse mammary tumor like virus sequences in breast milk from healthy lactating women
H Johal, C Ford, W Glenn, J Heads, J Lawson, W Rawlinson
Breast cancer research and treatment 129, 149-155, 2011
462011
Wnt signalling in gynaecological cancers: A future target for personalised medicine?
CE Ford, C Henry, E Llamosas, A Djordjevic, N Hacker
Gynecologic Oncology 140 (2), 345-351, 2016
452016
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20